This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
, No Gclids
Disease Info Card
Idiopathic Generalized Epilepsy
Information about Idiopathic Generalized Epilepsy: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Overview of Idiopathic Generalized Epilepsy
Most recent studies have shown that Idiopathic Generalized Epilepsy shares some biological mechanisms with absence-epilepsy, caprine-arthritis-encephalitis, complex-partial-seizures, convulsions, depressive-disorder, epilepsies-myoclonic, epilepsies-partial, epilepsy, epilepsy-generalized, epilepsy-temporal-lobe, febrile-convulsions, generalized-seizures, myoclonic-epilepsy-juvenile, myoclonus, partial-seizure, petit-mal-status, secondary-generalized-epilepsy, status-epilepticus, tonic-clonic-epilepsy.
Among the many pathways, these few ones have gauged particular interests from scientists studying Idiopathic Generalized Epilepsy, and have been seen in publications frequently: Aging, Brain Development, Cell Death, Circadian Rhythm, Cognition, Drug Resistance, Electron Transport, Hypersensitivity, Localization, Long-term Memory, Menarche, Menopause, Menstruation, Pathogenesis, Programmed Cell Death, Reflex, Response To Anticonvulsant, Short-term Memory, Synaptic Transmission, Transport
Quite a number of genes have been found to play important roles in Idiopathic Generalized Epilepsy, such as BRD2, CACNA1A, CHRNA4, CLCN2, CSF2, EP300, EXOSC10, GABRA1, GJA8, ISYNA1, KCNQ2, KCNQ3, LAMC2, RANGAP1, SCN1A, SLC17A5, SLC27A4, TNFSF14. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.